News

Politician accuses drug companies of overplaying dangers of H1N1

BMJ 2010; 340 doi: 10.1136/bmj.c198 (Published 12 January 2010)
Cite this as: BMJ 2010;340:c198

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Rory Watson
  1. 1Brussels

    Drug companies are being accused of unnecessarily raising fears over the H1N1 swine flu virus so as to increase profits by boosting sales of their new vaccines.

    The allegations, made in the parliamentary assembly of the Strasbourg based Council of Europe, are surfacing as several countries, notably the United Kingdom, France, and Germany, are looking to dispose of excess supplies of the unwanted vaccines (BMJ 2010;340:c170, 11 Jan, doi:10.1136/bmj.c170).

    Wolfgang Wodarg, a German Social Democrat MP and chairman of the assembly’s health subcommittee, is, with the support of a cross party group of Council of Europe parliamentarians, pressing for a pan-European investigation into the role of the companies in the current pandemic.

    “We have twice had …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular